Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.14 USD | +0.64% | -9.46% | -36.42% |
15/05 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
10/05 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.42% | 114M | |
+11.96% | 116B | |
+12.95% | 106B | |
-9.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.52% | 16.33B | |
+6.60% | 14.14B | |
+30.99% | 12.02B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Transcript : PDS Biotechnology Corporation Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-19-2023 01